发明名称 |
COMBINATION THERAPY USING PI3K INHBITOR AND MDM2 INHIBITOR |
摘要 |
The present disclosure pertains to a pharmaceutical combination comprising (a) an alpha- isoform specific PI3K inhibitor, (b) an MDM2 inhibitor, and optionally (c) a BCL-2 inhibitor; combined preparations and pharmaceutical compositions thereof; the uses of such combination in the treatment or prevention of cancer; and methods of treating or preventing cancer a subject in need thereof comprising administering a therapeutically effective amount of such combination. |
申请公布号 |
WO2017037586(A1) |
申请公布日期 |
2017.03.09 |
申请号 |
WO2016IB55075 |
申请日期 |
2016.08.25 |
申请人 |
NOVARTIS AG;CAPONIGRO, Giordano;HORN-SPIROHN, Thomas;LEHAR, Joseph |
发明人 |
CAPONIGRO, Giordano;HORN-SPIROHN, Thomas;LEHAR, Joseph |
分类号 |
A61K45/06;A61K31/4439;A61K31/496;A61K31/506;A61K31/5377;A61P35/00 |
主分类号 |
A61K45/06 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|